Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer

Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

(2015)   Oncotarget

Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment

(2013) Gregory S. Calip et al.   BREAST CANCER RESEARCH AND TREATMENT

Beta blockers and angiotensin-converting enzyme inhibitors’ purported benefit on breast cancer survival may be explained by aspirin use

(2013) Michelle D. Holmes et al.   BREAST CANCER RESEARCH AND TREATMENT

Long-Term Statin Use and Risk of Ductal and Lobular Breast Cancer among Women 55 to 74 Years of Age

(2013) J. A. McDougall et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Frequent Antibiotic Use and Second Breast Cancer Events

(2013) H. S. Wirtz et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study

(2013) Gitte Vrelits Sørensen et al.   JOURNAL OF CLINICAL ONCOLOGY

Mortality and Recurrence Risk in Relation to the Use of Lipid-Lowering Drugs in a Prospective Breast Cancer Patient Cohort

(2013) Stefan Nickels et al.   PLoS One

27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology

(2013) E. R. Nelson et al.   SCIENCE

Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer Outcomes

(2013) Young Kwang Chae et al.   Journal of Cancer

Use of Antihypertensive Medications and Breast Cancer Risk Among Women Aged 55 to 74 Years

(2013) Christopher I. Li et al.   JAMA Internal Medicine

Statin use and risk of breast cancer: a meta-analysis of observational studies

(2012) Krishna Undela et al.   BREAST CANCER RESEARCH AND TREATMENT

Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort

(2011) Patricia A. Ganz et al.   BREAST CANCER RESEARCH AND TREATMENT

Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins

(2011) Young Kwang Chae et al.   CANCER INVESTIGATION

Beta Blockers and Breast Cancer Mortality: A Population- Based Study

(2011) Thomas I. Barron et al.   JOURNAL OF CLINICAL ONCOLOGY

Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study

(2011) T. P. Ahern et al.   JNCI-Journal of the National Cancer Institute

Multimorbidity: An Issue of Growing Importance for Oncologists

(2011) Christine S. Ritchie et al.   Journal of Oncology Practice

The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer

(2010) E. K. Sloan et al.   CANCER RESEARCH

Statin use and cancer risk: a comprehensive review

(2010) Denise M Boudreau et al.   Expert Opinion On Drug Safety

Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates

(2010) Amanda I. Phipps et al.   MATURITAS

Evaluating Health Outcomes in the Presence of Competing Risks

(2010) Ravi Varadhan et al.   MEDICAL CARE

Angiotensin inhibition and malignancies: a review

(2009) T Rosenthal et al.   JOURNAL OF HUMAN HYPERTENSION

Association of Cardiometabolic Risk Factors and Prevalent Cardiovascular Events

(2009) Dan C. Malone et al.   Metabolic Syndrome and Related Disorders

Health Care Utilization and Costs by Metabolic Syndrome Risk Factors

(2009) D.M. Boudreau et al.   Metabolic Syndrome and Related Disorders

Is norepinephrine an etiological factor in some types of cancer?

(2008) Paul J. Fitzgerald   INTERNATIONAL JOURNAL OF CANCER